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Immunohistochemical study of the C5b-9 complex of complement in
human kidneys. The presence and localization of the C5b-9 neoantigens
of the terminal complement sequence, of antigens expressed by cleav-
age fragments of C3, and of Factor H antigens have been studied by
immunohistochemical techniques in morphologically normal adult hu-
man kidneys and in biopsy specimens from patients with a wide range
of renal diseases with and without immune deposits. In morphologically
normal kidneys, C5b-9 neoantigens were observed within all connective
matrices (arteriolar media, glomerular basement membrane (GBM),
mesangial matrix and tubular basement membrane). The C3d and C3g
antigens of the C3dg, and C3bi cleavage fragments of C3 and Factor H
antigens were found in similar locations. None of the matrices stained
for immunoglobulins. Immunoelectron microscopy demonstrated that
C3d, C3g, H antigens and the C5b-9 neoantigens were localized on
membranous and vesicular structures embedded in the connective
matrices. These structures represent cell membranes shed from adja-
cent cells as evidenced by their ultrastructural appearance and by the
fact that those which were in close vicinity to pedicels within the GBM
expressed the C3b receptor antigen, a specific marker for podocyte
membranes. Formation of C5b-9 complexes in the shielded environ-
ment of connective matrices may explain their persistance over long
periods of time in the absence of apparent immunopathological conse-
quences. Biopsies from pathological kidneys were classified into three
groups based on the pattern of glomerular staining with anti-C5b-9
antibodies. In the first group, a sparse mesangial labeling was seen,
similar to that observed in normal kidneys. In the second group,
abundant clusters of C5b-9 were seen in the same location as immune
deposits. Activation of the complement system to completion could be
documented in the absence of detectable C3 (C3c) antigen in glomeruli.
Immunoelectron microscopy demonstrated that C5b-9 neoantigens
were present on cell remnants in connective matrices in all specimens
that were studied. Labeled cell remnants were present in large amounts
in sclerotic matrices. C5b-9 neoantigens were constantly found on old
and large immune deposits, and absent or occasionally present on
recent and small immune deposits. In membranous nephropathy stage
I, proteinuria appeared to be independent of the presence or absence of
detectable CSb-9 neoantigens on immune deposits. Thus, the presence
of C5b-9 neoantigens in pathological renal tissue does not have an
univocal significance, and requires analysis of the localization of the
antigens and appropriate controls in order to assess the potential role of
C5b-9 in tissue damage.
Activation of the complement system results in cleavage of
C3 by C3 convertases, generation of C3b, cleavage of CS by
C3b-dependent C5 convertases, and formation either of a
membrane—bound C5b-9 (m) complex or of a cytolytically
inactive, hydrophilic SC5b-9 complex in the fluid phase [I]. As
the complement reaction progresses, C3b may be degraded into
C3bi by Factor I in the presence of Factor H [21. In the presence
of C3b receptor, C3bi may in turn be cleaved by I into C3c,
which is released in the fluid phase, and C3dg that remains
bound to the target membrane [3—5]. The C5b-9 complex
expresses neoantigens that allow its immunohistochemical de-
tection in tissues [1, 6]. C5b-9 neoantigens and neoantigens
expressed by polymerized C9 in C5b-9 complexes have been
found in renal biopsy specimens from patients with systemic
lupus erythematosus (SLE) [7] and in other human or experi-
mental immune complex diseases [8, 9]. The possibility has
been raised that the terminal complement complex may be
directly involved in mediating tissue damage [101 and in causing
proteinuria [11], Assessment of the role of C5b-9 in renal
disease is, however, complicated by the finding of C5b-9
neoantigens in the vasculature and in glomeruli in normal adult
human kidney [8, 121, and in biopsies from patients with
nephropathies without immune deposits [8].
In the present study, using immunofluorescence and immu-
noperoxidase techniques, we demonstrate that C5b-9 neoanti-
gens, antigens expressed by the C3bi and C3dg fragments, and
Factor H antigen are present in connective matrices in the
morphologically—normal human kidney. At an ultrastructural
level, the antigens were localized on round extracellular parti-
cles (REP) and striated membranous structures (SMS) which
represent cell remnants embedded within connective matrices.
CSb-9 complexes form naturally in these locations in the
absence of recognizable inflammatory processes. Sixty—seven
biopsy specimens from patients with various types of nephritis
were also investigated for the presence and localization of
C5b-9 neoantigens, C3, C3d and H antigens. In all specimens,
C5b-9 neoantigens were found on cell remnants in glomerular,
vascular and tubular connective matrices independently of the
presence or absence of immune deposits. Staining of immune
deposits with anti-CSb-9 was related to the type and the stage of
glomerular lesions.
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Renal specimens
Morphologically normal, adult renal tissue was obtained from
six renal biopsies performed for isolated microhematuria, and
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from normal parts of two nephrectomies performed for local-
ized renal carcinoma. Kidney specimens obtained between 1979
and 1984 from 67 adult patients (22 to 67 years old) with the
clinical and immunomorphological diagnoses listed below were
selected from the files of the Broussais hospital, Paris: isolated
proteinuria with microhematuria (one patient), minimal change
nephrotic syndrome (MCNS) (five), idiopathic membranoiis
glomerulonephritis (IMGN) (six), drug—induced membranous
glomerulonephritis (DMGN) (nine), idiopathic mesangial IgA
nephropathy (seven), idiopathic IgA nephropathy associated
with diabetic glomeruloscierosis (one), Schonlein—Henoch ne-
phropathy (two), membranoproliferative glomerulonephritis
(MPGN) type I (nine), diffuse crescentic glomerulonephritis
(DCGN) without anti-GBM antibodies (five), SLE (nine),
myeloma (two), light chain disease (LCD) (two), amyloidosis
(two), scieroderma with thrombotic microangiopathy (one),
Alport's syndrome (one), diabetic glomeruloscierosis (two),
drug—induced acute interstitial nephritis (one), acute transplant
rejection (two).
One portion of each specimen was fixed in alcoholic Bouin's
fixative for light microscopy; sections were stained with Mas-
son's trichrome or with silver solution following oxidation
according to Marinozzi. Another portion of each specimen was
processed for immunofluorescence as described below. Immu-
noelectron microscopy was performed on two normal renal
specimens and on seven biopsy specimens obtained from pa-
tients with the following diagnoses: SLE nephropathy with
diffuse endocapillary proliferation (type IV) (one), MPGN type
1 (two), SchOnlein—Henoch nephropathy (one); IgA nephrop-
athy associated with diabetic glomerulosclerosis (one), DMGN
(two).
Antibodies
Affinity—purified rabbit antibodies to human C5b-9 neoanti-
gens were prepared as described [13, 14]. Whole rabbit immune
sera were first absorbed with large amounts of human serum,
and specific anti-neoantigen antibodies were then isolated by a
membrane absorption—desorption procedure [14]. The speci-
ficity of the antibodies for C5b-9 neoantigens was confirmed by
immunoradiometric binding assays. Specific immunoglobulins
accounted for approximately 65% of total protein in the prepa-
rations. Fluoresceinated (FITC) goat lgG anti-rabbit lgG and
FITC rabbit anti-mouse IgG antiserum (Institut Pasteur, Paris,
France) were extensively absorbed with human lgG that had
been insolubilized with glutaraldehyde. Horseradish peroxidase
(HRP)-labeled goat F(ab')2 anti-rabbit IgG antibodies and HRP-
labeled rabbit F(ab')2 anti-mouse IgG antibodies were obtained
from lnstitut Pasteur (Paris, France). FITC anti-human IgG,
anti-human lgA, anti-human 1gM, anti-human Clq and anti-
human C3 antisera were obtained from Behringwerke (Marburg
lahn, FRG). The anti-C3 antiserum recognizes C3c antigenic
determinants expressed on the native C3 molecule and the C3b,
C3bi and C3c cleavage fragments of C3. Rabbit anti-human C3d
antiserum, which recognizes determinants expressed by native
C3, C3b, C3bi, C3dg and C3d, was obtained from the Dutch
Red Cross (Amsterdam, The Netherlands). Mouse monoclonal
antibody to the C3g antigen [15] was prepared as described.
Factor H was purified as described [16] and used as an
immunogen to obtain monospecific rabbit antibodies. Affinity
purified anti-human C5, anti-human C8, and anti-human C9
rabbit lgG antibodies [13], and rabbit antiserum to the human
C3b receptor [17] were raised as described.
Immunofluorescence techiques
Biopsy specimens that had been quick-frozen and stored in
liquid nitrogen were sectioned at 3 m thickness in a Bright's
cryostat (Instrument Company Ltd, Huntington, UK). Sections
were incubated with phosphate—buffered saline (PBS), pH 7,2,
for 20 mm at room temperature and overlaid with FITC
anti-IgG, anti-IgA, anti-IgM, anti-Clq, anti-C3 antisera or with
unlabeled antibodies for 30 mm at room temperature. For
indirect immunofluorescence (IF), sections were further incu-
bated for 30 mm at room temperature with FITC goat anti-
rabbit IgG antiserum or with FITC rabbit anti-mouse lgG
antiserum. The slides were examined by two investigators with
a Leitz microscope (Leitz Inc., Heerbrugg, Switzerland) using
epiillumination and an FITC/50 filter, Controls for indirect IF
were biopsies incubated with non-immune rabbit lgG and with
supernatant from mouse hybridoma NSI cells.
Conventional and immunoelectron microscopy
Normal part from two nephrectomies for localized renal
carcinoma were fixed by perfusing 4% paraformaldehyde in 0,1
M cacodylate buffer, pH 7.4 after catheterization of branches of
the renal artery. The specimens were post-fixed in 4% para-
formaldehyde during 24 hours. Tissue specimens from diseased
kidneys were fixed in 4% paraformaldehyde in 0.1 M cacodylate
buffer, pH 7.4, containing 0,5% glutaraldehyde for 4 hours. For
conventional electron microscopy, small tissue specimens were
post-fixed in 2% 0504 for one hour, dehydrated and embedded
in epon 812. For immunoelectron microscopy, the tissue spec-
imens that had been fixed in paraformaldehyde were cut into 30
,tm sections with a Smith—Farquhar tissue sectioner (Sorvall,
Paris, France). Sections from all specimens were incubated
with optimal dilutions of anti-C5b-9 antibodies for five hours at
room temperature with constant agitation. Additional sections
from normal specimens were treated with anti-C3g, anti-C3d,
anti-H and anti-C3b receptors antibodies. After washing in
cacodylate buffer overnight, the sections were incubated with
HRP-labeled F(ab')2 goat anti-rabbit IgG antibody or with
HRP-labeled F(ab')2 rabbit anti-mouse IgG antibody. The sec-
tions were washed in cacodylate buffer for 36 hours, and
peroxidase activity was revealed by reaction with diaminoben-
zidine and H202 [18, 19]. Sections were post-fixed with 0s04,
dehydrated and flat embedded in epon. Ultrathin sections were
cut using a Reichert OmU2 ultramicrotome (Reichert-.Jung,
Paris, France) and examined with a Zeiss Em9 or Em10 electron
microscope (Carl Zeiss Inc., Oberkochen, FRG). Controls
included sections treated with non-immune rabbit IgG or mouse
NSI lgG, and sections treated with HRP-labeled F(ab')2 anti-
bodies alone.
Results
Normal kidneys
Light microscopy and immunofluorescence. All specimens
were normal upon light microscopy examination and upon IF
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Fig. 1. Direct immunofluorescence with anti-C3 antiserum. Morphologically normal biopsy from a patient with isolated microhematuria. A
granular staining of juxtaglomerular arterioles (arrow) and of vascular pole is seen. The glomerular tuft is unlabeled; x273. Fig. 2. Indirect
itnmunofluorescence. Rabbit anti-human C5h-9 neoantigens antibodies. Morphologically normal biopsy from a patient with isolated
microhematuria. Granular staining is seen in mesangial areas. in Bowman's capsule (arrow) and in an arteriolar wall (arrow head); x273.
Fig. 3. indirect immunofluorescence. Rabbit anti-human C3d antiserum, Same glomerulus as in Figure 1. Mesangial areas and juxta-glomerular
arterioles are labeled; x273. Fig. 4. Indirect immunofluorescence. Rabbit anti-human Factor H antiserum. Same glomerulus as in Figure I.
Mesangial areas and juxta-glomerular arterioles are labeled; x276. Fig. 5. Indirect immunofluorescence. Rabbit anti-human C5b-9 neoantigens
antibodies. Interlobular artery. Same specimen as in Figure 2. Granular labeling is seen outside the spontaneously fluorescent elastic lamina (arrow
head) in aperimyocytic pattern; x276. Fig. 6. indirect immunofluorescence. Rabbit anti-human C5b-9 neoantigcns antibodies. Same specimen as
in Figure 2. Tubular basement membranes are labeled in a ribbon—like or granular pattern; x 178.
with anti-IgG, anti-IgA, anti-IgM, and anti-Clq antisera. A faint
and sparse labeling was occasionally seen in glomeruli, and
more often in arteriolar walls with anti-C3 antiserum (Fig. 1). In
contrast, a fine granular labeling was constantly seen in
glomeruli, mainly in mesangial areas, with anti-C5b-9
neoantigens antibodies (Fig. 2), anti-C3g, anti-C3d (Fig. 3). and
anti-H antibodies (Fig. 4) in all the specimens that were
examined. Occasional segmental labeling of Bowman's cap-
sules was observed with anti-C5b-9 (Fig. 2), anti-C3g, anti-C3d
and anti-H antibodies. In arteries and arterioles, anti-CSb-9
(Fig. 5), anti-C3g, anti-C3d, and anti-H antibodies constantly
labeled subendothelial spaces and perimyocytic matrices. A
similar pattern of glomerular and arteriolar labeling was found
with anti-CS, anti-C8, and anti-C9 antibodies. Segmental label-
ing of some tubular basement membranes (TBM) was seen in a
ribbon—like pattern with anti-C5b-9 (Fig. 6), anti-C3g and anti-
C3d antibodies but not with anti-H antibody. Anti-C3b receptor
antibodies stained all podocytes in glomeruli.
Conventional and immunoperoxidase electron microscopy.
The renal tissue was normal by conventional electron micros-
copy without delectable abnormalities of resident cells and
connective matrices, and without detectable immune deposits.
SMS and REP were seen in glomerular, tubular, and vascular
connective matrices as previously described in normal adult
human kidneys. By immunoeleetron microscopy, staining with
anti-C5b-9, anti-C3g, anti-C3d and anti-H antibodies was found
to be localized to SMS and REP within glomerular, vascular
and tubular matrices in both morphologically normal specimens
that were studied (Figs. 7—12). In glomeruli, labeled REP (Fig.
7) and SMS (Figs. 8—10) appeared isolated or in clusters, distant
(Fig. 8), or in close apposition to the plasma membrane of a
mesangial cell or of a podocyte [Figs. 7, 9, 10]. When SMS
appeared as a closed structure, staining was both circumferen-
tial and finely granular inside the structure (Fig. 8). The parts of
pedicels and of mesangial cytoplasmic extensions that were in
immediate vicinity of REP and SMS were often labeled (Fig.
10). In arteries and arterioles, staining with anti-C5b-9 (Fig. 11),
anti-C3g, anti-C3d and anti-H antibodies was observed on SMS
and REP in perimyocytic matrices and in the intima. In
Bowman's capsules and in TBM, staining with anti-C5b-9 (Fig.
12), anti-C3g and anti-C3d antibodies was seen on clustered
REP and vesicles of various sizes. Anti-H antibody stained
these structures with less intensity. Anti-C3b receptor antibody
diffusely stained the plasma membrane of podocytes and
stained some SMS close to the part of the pedicel that was
embedded in the GBM (Fig. 9C).
Diseased kidneys
Light microscopy and immunfluorescence. Biopsies were
classified into three groups based on the pattern of glomerular
staining with anti-C5b-9. In the first group, the pattern of-
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Fig. 7. Mesangial area. Morphologically normal tissue by optical,
immunofluorescence and standard electron microscopy from a nephrec-
tomy for localized carcinoma. A. Indirect immunoperoxidase staining
with rabbit anti-human C5b-9 neoantigens antibodies. B. Conventional
electron microscopy. Clumps of round extracellular particles are em-
bedded in the mesangial matrix (MM). The REP are clearly labeled in A.
Some clumps of REP (arrow) are located in continuity with a cytoplas-
mic extension of a podocyte (P); A x 19,600; B x 12,250.
fluorescence was similar to that observed in morphologically
normal kidneys, whether immune deposits were present or
absent in the biopsy specimens. In the second group, abundant
clusters of CSb-9 neoantigens were seen in enlarged mesangial
areas. As in the first group, C5b-9 deposits were independent of
the presence or absence of immune deposits. in the third group,
most C5b-9 neoantigens were found in the same location as
immune deposits. The clinical, morphological and immunohis-
tochemica! diagnoses from patients in each group are summa-
rized in Table I.
Group 1. Twenty—eight patients with the following diagnoses
were classified in group 1: MCNS (5), isolated proteinuria with
microhematuria (I), DMGN stage 1(7), igA nephropathy (2),
Schönlein—Henoch nephropathy (2), DCGN with segmental
glomerular necrosis (2), SLE nephropathy type 11(1), SLE
nephropathy type IV (I), myeloma (2), LCD (1), drug—induced
interstitial nephritis (1), acute transplant rejection (2),
scleroderma (I). The common feature of this group was that
staining with anti-CSb-9 antibodies was restricted to a fine
granular labeling in mesangial areas independently of the pres-
ence and location of immunoglobulin deposits. There was no
labeling with anti-C3 antibodies in 14 of 28 specimens; in the
remaining 14, labeling with anti-C3 was sparse and weak. In all
specimens, C3d and H antigens were detected in mesangial
areas. in specimens from biopsies of patients with DMGN (Fig.
13), SLE and SchOnlein—Henoch nephropathy, there was addi-
tional diffuse parietal staining with both anti-C3d and anti-H
antisera.
Group 2. Twelve patients were included in this group with the
following diagnoses: DCGN (3), IgA nephropathy (2), LCD
with nodular glomerulosclerosis (1), amyloidosis (2), diabetic
glomerulosc!crosis (2), IgA nephropathy associated with dia-
betic glomerulosclerosis (1), Alport's syndrome (1). The essen-
tial feature of this group was the presence of abundant clusters
Fig. 8. Mesangial area. Same specimen as in Figure 7. A. Indirect
immunoperoxidase staining with rabbit anti-human C5b-9 neoantigens
antibodies. B. Conventional electron microscopy. Closed striated mem-
branous structures (SMS) (arrow) and round extracellular particles
(REP) (arrow head) embedded in the mesangial matrix (MM). In A,
staining of the SMS is both circumferential and finely granular inside the
s(ructure.REP are also labeled (arrow head); A x 53,000; B x 57,000.
of C5b-9 neoantigens in sclerotic glomerular lesions, particu-
larly in enlarged mesangial areas (Fig. 14). Staining for C5b-9
neoantigens was not superimposable with immunoglobulin de-
posits if these were present. C5b-9 deposits were found in areas
of amyloid material. No staining with anti-C5b-9 antibodies was
found in areas of extracapillary cell proliferation. Extensive
C5b-9 deposition in all specimens contrasted with a weaker and
sparser staining with anti-C3 antibodies. The pattern of staining
with anti-C3d and anti-H antibodies was similar to that obtained
with anti-C5b-9.
Group 3. The twenty—seven patients in this group had im-
mune complex nephritis including: IMGN stage 1 (2), IMGN
stage 11(3), IMGN stage III (1), DMGN stage 11(1), DMGN
stage III (I), SLE nephropathy type IV (7), MPGN type 1(9),
IgA nephropathy (3). In all specimens, there was extensive
parietal and/or mesangial deposition of C5b-9 neoantigens in
areas of immunoglobulin and/or C3 deposition. Strong staining
for C3d and H antigens was seen in all immune deposits and in
extracellular matrices (Fig. 15).
in biopsies from the three groups, granular staining of the
intima and of perimyocytic matrices was observed in vessels
with anti-C5b-9, anti-C3d, and anti-H antibodies. Additional
perimyocytic staining with anti-IgG, and anti-Clq antibodies
was seen in most arteries in biopsies from 3 of 9 patients with
SLE. Hyalin deposits in arterioles stained for 1gM, Clq, C3,
C5b-9, C3d and H antigens. Numerous TBM were labeled with
anti-C5h-9 and anti-C3d antisera in all pathological specimens
that were examined. Staining of TBM was focal and increased
with the intensity of the sclerotic process (Fig. 14). In biopsies
from patients with SLE, tubulo-interstitial areas that stained for
IgG and Clq did not consistently stain with anti-C5b-9 antibod-
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Fig. 9. Glomerular basement membrane (GBM). Same specimen as in Figure 7. A. Indirect immunoperoxidase staining with rabbit anti-human
C5b-9 neoantigens antibodies. B. Conventional electron microscopy. Striated membranous structures (SMS) (arrow) underlying an extension of
a pedicel (P) is seen within the GBM. In A, SMS are strongly labeled. C. Indirect immunoperoxidase staining with rabbit anti-human C3b receptor
antiserum. The plasma membrane (arrow head) of pedicels (P) and SMS embedded in the GBM (arrow) in the vicinity of a pedicel are labeled;
A x 26,300; B x 36,000; C )< 65,000.
Fig. 11. Arteriolar wall. Indirect immunopcroxidase staining with rab-
bit anti-human C5b-9 neoantigens antibodies. Same specimen as in
Figure 7. Striated membranous structures (arrow) and round extracel-
lular particles (arrow head) are labeled. MY: myocyte; x32,000.
Fig. 10. Mesangial area, Indirect immunoperoxidase staining with
rabbit anti-human C5b-9 neoantigens antibodies. Electron microscopy.
Same specimen as in Figure 7. The distal part of a podocytic extension
(arrow head) and striated membranous structure (arrow) are in close
vicinity. Both are strongly labeled; x 45,000.
ies. In LCD, focal and segmental staining of TBM with anti-
C5b-9 antibodies contrasted with diffuse tubulo-interstitial dep-
osition of kappa or lambda light chain antigens.
Immunoelectron microscopy. Immunoelectron microscopy
was performed with anti-C5b-9 neoantigens antibodies on three
biopsies that had been classified in group I by indirect im-
munofluorescence (two biopsies from patients with DMGN,
stage I; one biopsy from a patient with Schönlcin—Henoch
nephropathy), one biopsy specimen from group 2 (diabetic
glomerulosclerosis with IgA nephropathy) and three biopsy
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Fig. 12. Tubular basement membrane (TBM). Same specimen as in
Figure 7. Indirect immunoperoxidase staining with rabbit anti-human
C5b-9 neoantigens antibodies. Ribbon—like labeling (arrow) within the
TBM surround unlabeled vesicular structures. x9,000.
specimens from group 3 (two biopsies from patients with
MPGN type I and one specimen from a patient with SLE
nephritis type IV), In specimens from group 1, strong staining
with anti-C5b-9 antibodies was localized to REP and SMS
within glomerular, vascular and tubular connective matrices.
Immune deposits were not stained or poorly labeled although
SMS and REP that were adjacent to or included in some
immune deposits were strongly stained (Fig. 16). In the speci-
men from group 2, the predominant feature was the presence of
an increased number of labeled REP and SMS in enlarged
connective matrices in areas of glonieruloscierosis (Fig, 17).
The increased staining with anti-C5h-9 neoantigens antibodies
of TBM was also due to the accumulation of cell remnants in
sclerotic TBM (not shown). In the three specimens from group
3, all subendothelial, subepithelial and rnesangial immune de-
posits were strongly and homogeneously labeled with anti-C5b-
9 neoantigens antibodies (Fig. 18). SMS and REP in connective
matrices were also labeled. No evidence for a lytic process that
would have led to necrosis of a resident glomerular cell was
'seen in any of the examined specimens. However, in the three
biopsy specimens from group 3, cytoplasmic extensions from
endothelial, mesangial, and epithelial cells that were in contact
with C5b-9 containing immune deposits, were altered with
hyaloplasmic clarification, and sometimes amputated. No ring
or cylindrical structures suggestive of inserted C5b-9 were seen.
Controls. All controls were negative.
Discussion
In the present study, complement activation products were
detected by IF and immunoelectron microscopy in renal biop-
sies from patients with various types of nephropathies, and also
in adult human kidney specimens that were normal upon light
Fig. 13. Drug—induced membranous nephropa thy with diffuse parietal
IgG deposits (stage I). A. Staining with anti-C5b-9 neoantigens anti-
bodies. Faint and sparsely granular labeling is seen in the glomerular
tuft. B. Staining with anti-igO. C. Staining with anti-C3d antibodies.
Diffuse granular parietal labeling is seen in the glomerular tufts. Strong
staining with anti-C3d antibodies contrasts with the weak staining with
anti-C5b-9 and the absence of staining with anti-C3 (data not shown);
x3lO.
microscopy, routine IF examination, and conventional electron
microscopy. By immunoelectron microscopy, C5b-9 neoanti-
gens of the terminal complement sequence were found on
striated membranous structures (SMS) and round extracellular
particles (REP) within connective matrices in all kidneys that
were examined, either normal or diseased. In diseased kidneys,
C5b-9 neoantigens were additionally found within large immune
deposits.
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IgA nephropathy
Schönlein—Henoch nephropathy
Diffuse crescentic glomerulonephritis
(DCGN)
Scieroderma with thrombotic
microangiopathy
SLE nephropathy, type II
type IV
Myetoma
Light chain disease (LCD)
Diabetic glomerulosclerosis
IgA nephropathy associated with diabetic
glomeruloscierosis
Alport's syndrome
Group 3
Idiopathic membranous nephropathy
stage 1
stage II
stage 111
Drug—induced membranous nephropathy
stage II
stage III
(1) 0
(I) + segm
M+ M+
M+ M+
Table 1. Pattern of staining with anti-IgG, anti-IgA, anti-IgM, anti-C3, anti-C3d, anti-H and anti-C5b-9 in 67 diseased kidneys
Disease category IgG
Pattern of glomerular staining
IgA 1gM C3 C3d H CSb-9
Group 1
Minimal change nephrotic syndrome
(MCNS)
Isolated microhematuria
Drug—induced membranous nephropathy
(DMGN) stage I
(2)b(I)
(I)
(1)
(1)
(5)
(2)
(2)
(2)
0
0
0
0
0
0
0
0
0
0
0
0
P+
0
MP+
0
0
M+
M+
MP+
0
M+
M+
0
0
0
0
M+
MP+
M+
M+
M+
M+ M+
M+ M+
M+ M+
M+ M+
M± M+
0 P+ P+ M+
P+ P+ M+
M+ M+ M+
M+ M+ MP+
0
MP+
M+
MP+ M+
0
0
0
M+
+ segm
0
0
M+
MP+
M+
M+
MP+
MP+
M+
0 M±
0
0
0
M±
+segm
0
0
0 0
0
0
MP+
M+
M+
0
M+
MP+
MP+
0
M+
M±
(1) 0
(I) M++
(1) + segm
(1) 0
(I) 0
(1) 0
(1) 0
(2) 0
(I) + segm
(1) ++ segm
(1) + segm
(1)
(I)
(1)
(1)
(1)
Drug—induced acute interstitial nephritis
Acute transplant rejection
Group 2
Diffuse crescentic glomerulonephritis
IgA nephropathy
Light chain disease
Amyloidosis
o M+ M+
o M+ M+
0
0
P+
0
0
o
o M+
o o
0
M+
M+
M+
M+
M+
M++
M + +
M++ +
M+++
o
o
o +segm
o M+
P± MP+
o
o M+
+' 0
P+
P+
+ segm
P+
M+
M++
P+
P+
+ segm
P+
MP+
+c
M+ M+++'
++e M+++c
M++0 M++ MP++ MP+
M+ MP++ MP+ M+++
P+ M++
+c
(2) 0
(1) 0 M+ + segm
(I) 0 0 P± M+
(2) P+ 0 P+
(2) P++ 0 0 P+
(1) P++ 0 0 0 P++
(I) P++ 0 P± P+ P++
(I) P++ 0 P+
(1) P++ 0 0 P++
P+
Pf+
P++
P+
P+ +
P+
p+ +
P+ +
P+
P+ +
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Table 1. Continued
Disease category
Pattern of glomerular staininga
IgG IgA 1gM C3 C3d H C5b-9
Membranoproliferative glomerulonephritis (2)
(4)
(1)
(I)
(1)
0
MP++
P±
+ segm
segm
0
0
MP++
+ segm
0
+
+
0
0
0
segm
segm
MP++
MP++
MP++
+ segm
+ segm
P++
MP+
MP+
P+
P+
P++
MP+
M+
+ segm
P+
MP++
MP++
MP++
MP+
P+
IgA nephropathy (1)
(2)
M±
M±
M+
M+
M±
M±
MP+
MP+
MP+
P+
MP+
P+
MP+
M++
SLE nephropathy, type IV (6)
(1)
MP++
MP++
MP+
MP+
MP±
MP++
MP++
MP++
MP++
MP+++
MP++
MP++
MP++
MP++
a Abbreviations are 0, no staining; segm, segmental, that is, affecting only part of the glomerulus; foc, focal, that is, affecting only some
glomeruli; M, mesangial; P, parietal; MP, mesangial and parietal. Intensity was graded from to + + +.
b Parenthesis indicates the number of patients in a diagnostic category with similar immunohistochemical findings in all patients studied.
C The topography of immune and complement deposits is superimposable with that of amyloid deposits
Fig. 14. Diabetic glomerulosclerosis. Staining with anti-C9 neoanti-
gens antibodies. Extensive C5b-9 deposits are seen in nodular mesan-
gial areas; x3lO.
Morphologically normal adult human kidney specimens in-
cluded six renal biopsies from patients from 19 to 40 years old
with minimal urinary abnormalities, and morphologically nor-
mal tissue from nephrectomies for localized carcinoma that
were performed in two patients of 52 and 60 years old. Immu-
noelectron microscopy was performed on the nephrectomy
specimens. Such material has previously been used to investi-
gate the presence of various antigens in normal renal tissue 117,
20, 221. By indirect immunofluorescence, staining for C5b-9
neoantigens, C3g and C3d antigens was observed within gb-
merular, arteriolar, and tubular connective matrices. The find-
ing of C5b-9 neoantigens in these locations was in agreement
with the previous observation of poby-C9 antigen in matrices of
normal human kidney $1 and of C5b-9 neoantigens in renal
connective matrices of normal rats [91. Staining was also
observed with anti-native CS and anti-C8 antibodies, indicating
the presence of true terminal complexes of the complement
sequence. Complement activation in connective matrices is
further supported by the presence of Factor H, which recog-
nizes C3b, and of the terminal C3dg cleavage fragment of C3, as
apparent from the presence of both C3g and C3d antigens in the
absence of C3c antigen [15]. Occasional staining of connective
matrices with anti-C3 antiserum did not correlate with the
constant finding of C3g, C3d, H, and C5b-9 antigens. By
immunoelectron microscopy, the sites of complement activa-
tion were identified as SMS, REP, and vesicular structures of
various sizes embedded in connective matrices. SMS, REP,
and vesicular structures have been observed in connective
matrices of normal [23—26] and diseased [23—291 human kidney
and in connective matrices of myocardium [30], seminiferous
tubules [31] and Bruch's membrane [32]. Their presence in
morphologically normal renal specimens does not imply the
presence of subclinical renal disease since SMS and REP have
been routinely observed in immediate renal graft biopsies
[23—261.
That SMS and REP represent fragmented cellular processes
is suggested by their ultrastructural appearance [23—27, 301 and
location. The finding in this study that those SMS, which are
located in the subepithelial part of the GBM, stained for C3b
receptor antigen, a specific marker for podocytic membranes
[17], and further suggests that SMS are plasma membranes
detached from adjacent cells. Terminal C5b-9 complexes could
form on primarily shedded membrane remnants. Thus, killed
human kidney cells [33], heart mitochondrial membranes in
ischemic myocardial cells [341, and cytoskeletal intermediate
filaments in cultured human embryonal fibroblasts [35] activate
the complement system in the absence of antibody. Alterna-
tively, attachment of C5b-9 to cell membranes could lead to
secondary shedding of the afflicted membrane areas. The latter
possibility is suggested by the present finding of C5b-9
neoantigens on podocytic and mesangial cytoplasm in immedi-
ate vicinity of SMS and REP. In either case, triggering of the
complement cascade on cell membranes and/or remnants might
be due to reduction or loss of regulatory membrane factors that
normally inhibit activation of the complement system on autol-
ogous cells [36]. The presence of Factor H and of C5b-9
neoantigens in similar locations indicates that activation and
control of complement coexist on cell membranes, although
Fig. 15. Idiopathic inembranous nephropathy, stage II. Serial sections
of the same glomerulus stained with anti-C5b-9 neoantigens antibodies
(A), anti-C3d antibodies (B) and anti-H antibodies (C). A diffuse
granular parietal pattern of staining is seen with each of the three
antibodies, similar to that observed with anti4gG and anti-C3 (data not
shown); x310.
Fig. 16. Electron micrograph of a glomerulus from a patient with
drug—induced membranous nephropothy stained by immunoperoxidase
with unti-(5h-9 neoantigens antibodies, Subepithelial deposits are not
(arrow head) or poorly and heterogeneously (arrow) labeled. A striated
membranous structure adjacent to a subepithelial deposit is strongly
stained (double arrow); x 11,000.
activation may escape control and result in formation of C5b-9
complexes. CSb-9 complexes are remarkably stable structures
[1] and probably remain trapped in connective matrices,
inacessible to inflammatory cells, over long periods of time.
Their generation in normal tissues may be of no im-
munopathological consequence because of the shielded envi-
ronment in which the reaction occurs.
Kidney biopsies from 67 individual patients representing a
large panel of clinical and irumunohistochemical diagnoses were
also investigated for the presence of C5b-9 neoantigens by IF.
Fig. 17. Electron micrograph of a gloinerulus from a patient with
diabetic glomeruloscierosis stained by immunoperoxidase with anti-
G5h-9 neoantigens antibodies. The enlarged glomerular basement mem-
brane and mesangial matrix contain numerous striated membranous
structure (SMS), round extracellular particles (REP) and other cell
remnants. SMS, REP and cell remnants are strongly labeled; x35,000.
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Fig. 18. Electron micrograph of capillary walls in a glomerulus from a
patient with SLE nephropathy type IV, stained by immunoperoxidase
with anti-C'5h-9 neoanhigens antibodies. All subendothelial (arrow) and
subepithelial (arrow head) immune deposits are strongly and homoge-
neously labeled; x25,500,
Seven biopsies were studied by immunoelectron microscopy
The pattern of glomerular staining with anti-C5b-9 antibodies as
discerned by indirect IF permitted classification of the biopsies
into three categories. In the first group, staining for C5b-9
neoantigens was similar with that of normal kidney. By immu-
noelectron microscopy, C5b-9 neoantigens were localized to
SMS and REP. This group included 14 biopsies without immu-
noglobulin deposits and 13 biopsies with small or segmental
immune deposits, of which seven showed an early stage of
DMGN. In these cases, deposition of C5b-9, which occurred in
the absence of immunoglobulin deposits or in a different loca-
tion from that of immunoglobulins, was unlikely to represent
the effector mechanism by which immune deposits were patho-
genic. C5b-9 neoantigens, however, could be present in immune
deposits in quantities below the threshold of their detection.
The presence of C3d and H antigens in the same location as that
of parietal IgG in DMGN suggest that complement may be
activated in situ, hut that effective regulation prevents recruite-
nient of the terminal effector sequence.
In the second group of biopsies, anti-C5b-9 antibodies exten-
sively stained enlarged mesangial areas in the presence or
absence of labeled glomerular immune deposits. The strong
mesangial staining derived from increased amounts of labeled
SMS and REP in glomerular sclerotic areas, as revealed by
immunoelectron microscopy. The increased amount of cell
remnants in sclerotic matrices [23—25, 27, 28] account for the
previous observation of abundant deposits of "poly-C9" anti-
gen in diabetic glomerulosclerosis, hypertensive nephrosclero-
sis, and end—stage kidneys [8]. That cell remnants also stain for
C3d and H explains the increase in staining intensities for these
antigens in glomerular and tubular sclerotic matrices in group 2
as compared with group 1.
The third group comprised biopsies with extensive suhepi-
thelial, subendothelial and/or mesangial immune deposits, In all
biopsies from this group, the pattern of staining with anti-C5b-9
antibodies was similar to that of immunoglobulins. Upon immu-
noelectron microscopic examination, there was strong and
homogeneous staining of all immune deposits in addition to
staining of cell remnants. Immune deposits also stained for C3d
and H antigens, indicating that activation and regulation of
complement occur on large immune deposits. C5b-9 deposition
probably ensues when activation processes escape control.
Staining for C5b-9 that was observed in subepithelial deposits
only at late stages of DMGN and only at late stages of de novo
MGN in transplant recipients [37] indicates local rearrangement
of immune deposits [38], and suggests that C5b-9 is unrelated to
the pathogenesis of proteinuria. In this respect, the pathogen-
esis of proteinuria in DMGN stage I would differ from that of an
experimental model of MON in rabbits in which proteinuria is
dependent on normal C6 activity [111.
Evaluation of immunohistochemical data on renal biopsies
stained with anti-C5b-9 antibodies requires careful interpreta-
tion; sparse and granular labeling in connective matrices should
not be regarded as abnormal, since C5b-9 is normally found on
cell remnants that are embedded in connective matrices. Con-
versely, the presence of C5b-9 neoantigens is of pathological
significance when the antigens are found within immune depos-
its and/or are present in abundant clusters in sclerotic matrices
because of the increased density of labeled cell remnants in the
latter circumstances. The pathological occurence of CSb-9
neoantigens does not strictly correlate with positivity for C3,
that is some biopsies were negative for C3 but positive for
C5b-9, which may derive from the extreme stability of C5b-9 as
opposed to C3 antigens.
Complement—mediated damage to a membrane results from
the insertion in the lipid bilayer of C5b-9 complexes to create
hydrophilic transmembrane channels [1). Although erythro-
cytes are effectively lyzed by small amounts of C5b-9, nucle-
ated cells are more resistant to membrane attack by comple-
ment. Furthermore, cell membranes are relatively resistant to
lysis by autologous, as compared with heterologous comple-
ment [39]. Although C5b-9 has been found in this and in
previous [7, 81 studies to be present in various types of renal
lesions, its direct role as a pathogenic mediator of renal injury
remains speculative. The present observation of C5b-9 neoan-
tigens on cell remnants in normal human adult kidney could
suggest that complement plays a physiological role in the
normal shedding process of plasma membranes from aging
cells. Recognition of the diversity in the presence and localiza-
tion of C5h-9 neoantigens in diseased kidneys is relevant to the
understanding of the role of the effector sequence of comple-
ment in the pathogenesis of immune and non-immune renal
diseases.
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